Articles On Medical Developments International (ASX:MVP)

If you’re wanting a little exposure to the small side of the market, then it could be worth checking out the two small cap ASX shares that Bell Potter rates as a buy. Here’s what the broker is saying about them: Ai-Media Technologies...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIS)) - Aeris Resources ((AGI)) - Ainsworth Game Technology ((ALX)) - Atlas Arteria ((ATA)) - Atturra ((AUA)) - Audeara ((ASB)) - Austal ((BUB)) - Bubs Australia ((CCX))...

Imricor establishes first iCMR site in Switzerland MVP to seek market opportunities in the US  Nyrada delays launch of Phase I/IIa study   Imricor signs with University Hospital Lausanne MRI-compatible medical devices specialist Imricor M...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Medical Developments International (MVP) cancels plans for clinical trials of its Penthrox drug in China and subsequent commercial launch in the country MVP says “extended delays” to the expected timeline for clinical trial outcomes was...

The PolyNovo Ltd (ASX: PNV) share price is coming under pressure today as the S&P/ASX 300 Index (ASX: XKO) faces another sea of red. At the time of writing, the PolyNovo share price has slid 5.7% to last change hands at $1.65 apiece. M...

As nerves mount for players on both NRL Grand Final sides preparing to line up at Staiudm Australia on Sunday night, it’s worth remembering the myriad enterprises that enable sportspeople to leap higher and kick further – while also tending...

The Medical Developments International Ltd (ASX: MVP) share price is up 4.6% as we head into the lunch hour. Medical Developments shares closed yesterday at $1.85 and are currently trading for $1.93. The ASX healthcare company, focused on...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Several ASX health stocks have...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a small gain. At the time of writing, the benchmark index is up 0.1% to 7,024.3 points. Four ASX shares that have failed to follow the market hi...

The Medical Developments International Ltd (ASX: MVP) share price is drifting deep into the red in early trade on Monday. At the time of writing, the share trades 17% lower at $1.99 following the release of a company announcement. What...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Morgans takes conservative app...

The ASX 200 is pretty flat, small caps up circa 0.5%  Materials and energy dragging locally Alibaba reports tonight: analysts predicting 30 thieves, down from previous high of 40   Around lunchtime, the major banks started passing on the...

Medical Developments International (MVP) launches a $30 million capital raise to execute further growth The company will aim to raise $15 million from a placement and $15 million from a one-for-9.5 non-renounceable entitlement offer The ne...

The Medical Developments International Ltd (ASX: MVP) share price is on ice today following a company requested trading halt. The ASX granted the trading pause before market open. Prior to being put into the trading halt, the last bid fo...

Medical Developments International (ASX:MVP) has announced a fully underwritten capital raising of $30 million.

In times of great uncertainty the Australian healthcare sector can offer investors plenty of choice, with varying degrees of risk and opportunities. -Australia’s healthcare sector has seen record government investment-Global pandemic has ac...

What are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up for ASX biotechs in 2022 Risks of investing in biotechs Historical data shows that biotech is one the best sectors to put your money in ov...

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Medical Developments International (ASX:MVP) has announced the appointment of Tara Eaton as its general counsel and company secretary.

The deep sell down of the US biotech sector has resulted in the valuation of many of the ASX-listed life science plays looking a tad sickly, too. Arguably, many of them were overvalued in the first place. But in many cases the companies ar...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. At the time of writing, the benchmark index is up 0.1% to 7,105.7 points. Four ASX shares that are climbing more than most are listed...

Medical Developments International (MVP) shares jump after the US Food and Drug Administration lifts its hold on pain relief drug, Penthrox This means that the company can immediately begin preparing for its phase three US clinical trial...

The ASX 200 Health Index (XHJ) is trading lower by 0.27% at the time of writing, compared to the broader index which is falling by 0.56%. Pain relief specialist Medical Development International (ASX:MVP) announced that the US FDA has uncon...

The Medical Developments International Ltd (ASX: MVP) share price has returned from its trading halt with a bang. In morning trade, the medical device company’s shares are up a massive 32% to $4.50. Why is the Medical Developments Internat...

The Medical Developments International Ltd (ASX: MVP) share price will be on watch on Friday. This follows the release of the healthcare company’s half year results after the market close. Medical Developments International share price on...

The ASX 200 Health Index (XHJ) has fallen by 1.26% at the time of writing, compared to the broader index which is down by 0.12%. Medical device company OncoSil Medical (ASX:OSL) surged as high as 25% up today, after its device was granted a...

Alloggio Group (ASX:ALO), didn’t have a positive debut on the ASX last week but that didn’t stop one director from buying more on market. The holiday accommodation manager listed at 20 cents per share but fell as low as 15 cents on debut am...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week The Healthc...

The Medical Developments International Ltd (ASX: MVP) share price has fallen to a new 52-week low today. The company hasn’t released any news for nearly a fortnight. However, the last time the market heard from Medical Developments, it sha...

Highlights In the opening trade, the ASX 200 was trading 4.8 points up at 7,507.8, with the materials sector stocks opening in green on soaring commodities prices. Six out of the 11 sectors are trading in green, with the Materials sect...

The Medical Developments International (ASX: MVP) share price is lower after the company released its full-year results for FY21. At the time of writing, shares in the company are trading for $3.93 – down 2.48%. The ASX All Ordinaries Inde...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) on course to end the week in a subdued fashion. At the time of writing, the benchmark index is down slightly to 7,335.6 points. Four ASX shares that are falling more than most are li...

The Medical Developments International Ltd (ASX: MVP) share price has come under pressure on Friday. At the time of writing, the medical device company’s shares are down 8% to a 52-week low of $4.03. This means the Medical Developments Int...

The deal gives IHL a global partner to develop the drug and navigate the global regulatory backdrop. Incannex Healthcare (ASX:IHL) flagged another key step forward this morning in the clinical development and manufacture of its IHL-216A tre...

With health issues at the global forefront over the past year, it’s no surprise that Australia’s health-related sector has also grown substantially. But the industry was already emerging even before COVID-19. Excellent research facilities a...

Every so often, I like to take a look to see which shares have experienced meaningful insider buying. This is because insider buying is often regarded as a bullish indicator, as few people know a company and its intrinsic value better than...

Source: REDPIXEL.PL, Shutterstock Summary Medical Developments International highlighted that despite a challenging H1, the Company anticipates a much stronger H2 FY2021. Future performance to be driven by easing restrictions, ongoing...

The Medical Developments International Ltd (ASX: MVP) share price has been a strong performer on Monday. In afternoon trade, the medical device company’s shares are up 7% to $5.37. Why is the Medical Developments International share price...

The Medical Developments International Ltd (ASX: MVP) share price was a strong performer on Thursday. The healthcare company’s shares closed the day a sizeable 5% higher at $7.18. This means the Medical Developments International share pri...

The Rhythm Biosciences Ltd (ASX:RHY) share price has rocketed over 640% for the past twelve-month period. From the beginning of November alone, the share price has soared over 355%.  For the past few weeks, we’ve been watching Rhythm Biosc...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.5% to 6,677.4 points. Four shares that have failed to follow the market higher today are liste...

The Medical Developments International Ltd (ASX: MVP) share price has returned from its trading halt and is sinking lower on Monday morning. In early trade the healthcare company’s shares were down as much as 8.5% to $6.51. The Medical Dev...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) looks set to end the week on a strong note. At the time of writing, the benchmark index is up 0.5% to 6,646.2 points. Four shares that have failed to follow the market higher today ar...

The Medical Developments International Ltd (ASX: MVP) share price will be on watch on Friday following the release of an update after the market close. What did Medical Developments International announce? This afternoon Medical Developmen...

Lifespot Health (ASX: LSH) is further enhancing its leadership team and topping up cash reserves as it advances the development of its medical cannabis inhaler device program it claims will “significantly evolve the treatment options for pa...

The S&P/ASX 200 Index (ASX: XJO) has risen by 4.67% since last Friday’s close (6 November) to 6,466 points. Global investors have snapped up pandemic-hit shares after Pfizer Inc. (NYSE: PFE) indicated that its COVID-19 vaccine had prov...

The Medical Developments International Ltd (ASX: MVP) share price is on course to finish the week on a low note. In afternoon trade the healthcare company’s shares are down over 2% to $5.30. Why is the Medical Developments International sh...

The Medical Developments International Ltd (ASX: MVP) share price is pushing higher on the day of its annual general meeting. In afternoon trade the healthcare company’s shares are up 2.5% to $5.44. In case you missed the event, I thought...